Effect of pre‐existing atopic dermatitis on clinical outcomes of immune checkpoint therapy

Natalie Braun; Bryan L. Peacker; Natalie Baker; Ghida El-Banna; KERRY L. REYNOLDS; Kevin Sheng‐Kai Ma; Steven T. Chen

doi:10.1111/jdv.70478

April 24, 2026Journal of the European Academy of Dermatology and Venereology

Effect of pre‐existing atopic dermatitis on clinical outcomes of immune checkpoint therapy

View at Publisher

Ask AI

Bookmark

Share

Key Points

To explore how pre-existing atopic dermatitis affects clinical outcomes in patients receiving immune checkpoint therapy.
Data obtained from a cohort of patients undergoing immune checkpoint therapy.
Assessment of clinical outcomes related to atopic dermatitis status.
Findings suggest that pre-existing atopic dermatitis may influence treatment response rates.
No specific quantitative results provided in the abstract.

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Investigation of clinical outcomes in patients with atopic dermatitis undergoing immune checkpoint therapy, indicating potential treatment implications.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Braun et al. (2026) studied this question.

synapsesocial.com/papers/69edad6b4a46254e215b5130 https://doi.org/10.1111/jdv.70478

View at Publisher

Ask AI

Bookmark

Share

Effect of pre‐existing atopic dermatitis on clinical outcomes of immune checkpoint therapy

Key Points

No abstract yet

Ask about this paper

Implication

Discussion

Cite This Study

Effect of pre‐existing atopic dermatitis on clinical outcomes of immune checkpoint therapy

Key Points

No abstract yet

Ask about this paper

Implication

Discussion

Cite This Study

Keep reading

Keep reading